Indy Star interviewed Thomas F. Imperiale, M.D., about his study published in the New England Journal of Medicine. This next generation multi-target stool DNA colorectal cancer screening test detects 94 percent of colorectal cancers and has the best performance for detection of both colorectal cancer and advanced precancerous polyps of any noninvasive colorectal cancer screening test.
-
Research
- Experts
In The News
View AllNew York Times features Dr. Malaz Boustani
Malaz Boustani, M.D., PhD, was featured by The New York...
Influence
View AllScreening for Syphilis Infection During Pregnancy: US Preventive Services Task Force Reaffirmation Recommendation Statement
Published in JAMA. Here is a link to the article....
- Opportunities
Featured Fellowship
View all- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
- Experts
March 19, 2024
Indy Star interviewed Dr. Thomas F. Imperiale

"*" indicates required fields